1 Hour Ago
Holland seems so sketchy to me. Topic, Buzelis, Holland are my big 3 to avoid imho and not saying they won't make it, in fact I could see each one carving out a value niche and could see Topic being a downright star. Just wary of the bust potential and medicals in Topic's case.
Holland actually...